1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid
C23H34N8O3 — CID 155415195
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid
1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid (PubChem CID 155415195) has the molecular formula C23H34N8O3 and a molecular weight of 470.58 g/mol. Its IUPAC name is 1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid.
Molecular Properties
| Compound Name | 1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid |
|---|---|
| PubChem CID | 155415195 |
| Molecular Formula | C23H34N8O3 |
| Molecular Weight | 470.58 g/mol |
| Exact Mass | 470.28 |
| IUPAC Name | 1-[4-(2-aminoethylamino)-6-[4-(2-ethoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl]piperidine-4-carboxylic acid |
| SMILES | CCOc1ccccc1N1CCN(c2nc(NCCN)nc(N3CCC(C(=O)O)CC3)n2)CC1 |
| InChI | InChI=1S/C23H34N8O3/c1-2-34-19-6-4-3-5-18(19)29-13-15-31(16-14-29)23-27-21(25-10-9-24)26-22(28-23)30-11-7-17(8-12-30)20(32)33/h3-6,17H,2,7-16,24H2,1H3,(H,32,33)(H,25,26,27,28) |
| InChIKey | YQLKXKUDNBNGKJ-UHFFFAOYSA-N |
| XLogP | 1.27 |
| TPSA | 132.97 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.58 |
| LogP ≤ 5 | 1.27 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155415195 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.